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Abstract
Background: Pulse wave velocity (PWV) is a biomarker for arterial stiffness, clinically assessed by applanation
tonometry (AT). Increased use of phase-contrast cardiac magnetic resonance (CMR) imaging allows for PWV
assessment with minor routine protocol additions. The aims were to investigate the acquired temporal resolution
needed for accurate and precise measurements of CMR-PWV, and develop a tool for CMR-PWV measurements.
Methods: Computer phantoms were generated for PWV = 2–20 m/s based on human CMR-PWV data. The PWV
measurements were performed in 13 healthy young subjects and 13 patients at risk for cardiovascular disease. The
CMR-PWV was measured by through-plane phase-contrast CMR in the ascending aorta and at the diaphragm level.
Centre-line aortic distance was determined between flow planes. The AT-PWV was assessed within 2 h after CMR.
Three observers (CMR experience: 15, 4, and <1 year) determined CMR-PWV. The developed tool was based on the
flow-curve foot transit time for PWV quantification.
Results: Computer phantoms showed bias 0.27 ± 0.32 m/s for a temporal resolution of at least 30 ms. Intraobserver
variability for CMR-PWV were: 0 ± 0.03 m/s (15 years), -0.04 ± 0.33 m/s (4 years), and -0.02 ± 0.30 m/s (<1 year).
Interobserver variability for CMR-PWV was below 0.02 ± 0.38 m/s. The AT-PWV overestimated CMR-PWV by 1.1 ± 0.
7 m/s in healthy young subjects and 1.6 ± 2.7 m/s in patients.
Conclusions: An acquired temporal resolution of at least 30 ms should be used to obtain accurate and precise thoracic
aortic phase-contrast CMR-PWV. A new freely available research tool was used to measure PWV in healthy young
subjects and in patients, showing low intra- and interobserver variability also for less experienced CMR observers.
Keywords: Aorta, Pulse wave velocity, Temporal resolution, Magnetic resonance imaging, Phase contrast, Applanation
tonometry
* Correspondence: erik.hedstrom@med.lu.se
2Lund University, Skane University Hospital, Department of Clinical Sciences
Lund, Clinical Physiology, Lund, Sweden
6Lund University, Skane University Hospital, Department of Clinical Sciences
Lund, Diagnostic Radiology, Lund, Sweden
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Dorniak et al. BMC Cardiovascular Disorders  (2016) 16:110 
DOI 10.1186/s12872-016-0292-5
Background
Aortic stiffness is related to progressive structural changes
of the aortic wall with normal aging, [1] but also dependent
on cardiovascular disease (CVD) risk factors such as hyper-
tension independent of end-stage renal disease, glucose in-
tolerance, diabetes, and obesity [2, 3]. Pulse wave velocity
(PWV) can be used as a biomarker for aortic stiffness, and
can predict CVD outcome beyond traditional risk factors
[4]. Further, as arterial stiffness occurs earlier than luminal
changes, [5] PWV has a potential as an early marker for
atherosclerosis. The PWV is defined as the distance be-
tween two measurement planes divided by the difference
in time between pulse waves at these measurement planes.
Cardiac magnetic resonance (CMR) imaging is increas-
ingly used for cardiovascular assessment, and minor adjust-
ments to a routine CMR protocol yields data for PWV.
The CMR-PWV has been previously validated [6, 7] and is
thus an attractive option for assessment of aortic stiffness,
giving prognostic information at low extra cost.
Applanation tonometry (AT) is another method for
assessing PWV, and this method is both generally available
and well used in clinical routine as it is easy to apply
[8]. The AT measures PWV on a more global arterial
scale compared with CMR, between carotid and femoral
arteries, whereas CMR usually is applied regionally in the
aortic arch or thoracic aorta [9, 10]. The CMR-PWV
measurements can however also be performed in a glo-
bal fashion similar to AT-PWV covering the abdominal
aorta or iliac arteries [1, 11]. Depending on the extent of
aorta included in CMR-PWV measurements, the CMR-
PWV values could be expected to not be interchangeable
with AT-PWV, particularly important in follow-up studies.
All PWV methods are susceptible to sampling errors,
CMR-PWV particularly so related to noise and temporal
resolution, whereas the main limitation for AT-PWV is
the estimated distance between flow curve measurement
points. With the increasing availability of CMR, the
paucity of available software to assess CMR-PWV is
also viewed as a major limitation to the wider use of
CMR-PWV [12].
The aims of this study were therefore to 1) investigate
the acquired temporal resolution needed for accurate
measurements of CMR-PWV; and 2) to provide a tool
for CMR-PWV measurements and use this to compare
CMR-PWV with the clinical standard AT-PWV, by expe-
rienced and less experienced CMR observers.
Methods
Study populations and protocol
The local Ethics Committee approved the study and all
subjects provided written informed consent.
First, a set of simplistic computer phantoms was created
in order to derive the adequate temporal resolution for
accurate and precise quantification of CMR-PWV. The
following acquisitions of CMR flow data in humans
were performed using an acquired temporal resolution
above this cut-off.
Irrespective of the PWV measurement method applied,
the PWV tend to be lower and less dispersed in younger
healthy individuals and higher and more scattered in older
subjects, and also increase with presence of cardiovascular
disease (CVD) risk factors. Therefore, PWV was obtained
by both CMR and AT in younger healthy subjects and in
older patients with CVD risk factors.
Healthy subjects (n = 13, median age 26 years, range
18 – 43 years, 5 women) were included in whom CMR
was performed as part of routine workup due to positive
family history or clinical findings raising suspicion of
one of the following genetic/familial disorders: arrhyth-
mogenic right ventricular cardiomyopathy, left ventricu-
lar non-compaction, Marfan syndrome or hypertrophic
cardiomyopathy. In all included subjects the CMR re-
sults and other clinical examinations including genetic
testing where appropriate were normal. The CMR was
considered normal if all volumes, LV mass and thickness
and regional and global function were within age and
gender reference limits, and valvular pathology including
regurgitation/stenosis was not present.
Consecutive patients (n = 13, median age 61 years,
range 52 – 72 years, 7 women) were included with vari-
able CVD risk profile including dyslipidaemia, hyperten-
sion, and history of coronary artery disease. Exclusion
criteria were any acute cardiovascular condition such as
myocarditis, acute coronary syndrome or overt heart
failure within 3 months prior to inclusion, complex
congenital heart disease, known familial or genetic car-
diomyopathy or aortic stenosis or regurgitation.
Applanation tonometry was used as a clinical standard
for comparison, and performed within 2 h after the CMR
examination. The brachial arterial blood pressure was also
measured in the supine position with a sphygmomanom-
eter in all patients, in conjunction with AT.
Computer phantoms
The velocity profiles and typical aortic centre-line dis-
tance between flow measurement planes were extracted
from normal subject data with a heart rate of 60 beats
per minute and 40 time frames, corresponding to a true
temporal resolution of 25 ms. The velocity profiles were
up-sampled with cubic interpolation to 10 000 time
frames over a cardiac cycle, corresponding to a time reso-
lution of 0.1 ms. Given a known PWV and the distance
between flow measurement planes the temporal shift
between flow curves was calculated. A set of such fixed
temporal shifts was introduced to correspond to known
PWV in the range of 2–20 m/s (in 10 steps of 2 m/s).
After adding the temporal shift, the velocity profiles were
down-sampled to between 20–40 time frames (21 steps
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per cardiac cycle), resulting in temporal resolutions of
25–50 ms. In the upsample/downsample process the
highest temporal resolution thus was kept below the
originally collected data based on 40 time frames, i.e.
25 ms. To ensure a mathematically correct down-sampling
process optimal anti-aliasing filters were applied. The max-
imal percentage error between calculated PWV and true
PWV was determined for each computer phantom by test-
ing each combination of number of time frames and PWV.
In total 210 (10 × 21) phantoms were evaluated. The deter-
mination of the cut-off for number of time frames to be
used for adequate temporal resolution was based on visual
inspection of identity plots and the quantitative bias be-
tween calculated and true PWV.
CMR imaging
Patients were imaged in the supine position using either
a 1.5 T MR scanner (Siemens Aera, Erlangen, Germany)
with an 18-element phased array cardiac coil (n = 14) or
a 3 T MR scanner (Philips Achieva 3.0 T TX, Eindhoven,
the Netherlands) with a 32-channel InVivo cardiac coil
(n = 12). Oblique sagittal slices covering the thoracic
aorta (producing the so-called ‘candy-cane view’) and 1
phase-contrast image for aortic flow measurements at
the level of the diaphragm were added to the routine
protocol, which already included a phase-contrast flow
acquisition in the ascending aorta. The oblique sagittal
slices were acquired either with a HASTE (half fourier
single shot turbo spin echo) or a 3D turbo spin-echo
sequence. For quantitative flow measurements, a 2D
phase-contrast gradient recalled echo (GRE) sequence
with retrospective ECG-gating was used. Adequate vel-
ocity encoding (Venc) values were selected using a Venc-
scout and set to between 150–250 cm/s for through plane
flow quantification. Typical parameters for the quantita-
tive flow phase-contrast GRE sequence were TR/TE = 20/
3 ms, flip angle = 10/20°, 1.3 × 1.3 × 8 mm3. Fifty (Siemens)
or 40 (Philips) velocity-encoded images were acquired per
cardiac cycle, as determined after the computer phantom
experiment. The typical segment size was approximately
20 ms for both scanners, ranging from 15 – 27.5 ms. The
acquisition matrix in the phase encoding direction was
adapted if necessary to meet a segment size < 30 ms.
CMR image analysis
A new module for PWV was introduced in the software
Segment (http://www.medviso.com) [13]. Aortic pulse
wave travel distance was measured manually along the
centre-line of the aorta in the oblique sagittal aorta im-
ages, between the acquired flow measurement planes in
the ascending aorta and at the level of the diaphragm. For
quantitative flow curves, automatic vessel segmentation
was performed with manual corrections where needed.
Delineations were performed in magnitude images and
guided by phase-contrast images where appropriate.
The flow curves from the ascending aorta and the
aorta at the level of the diaphragm were superimposed
and intersecting tangents between upslope and baseline
were determined. The time-to-foot (TTF) approach was ap-
plied as this has been shown to be reliable for CMR-PWV
[9]. In short, a regression line was fitted to the maximum
upslope of each of the two flow curves representative of the
ascending aorta and the aorta at the level of the diaphragm.
The points at which these upslope tangents intersected the
baseline tangents were labelled as the respective intersec-
tion points (Fig. 1). Prior to the upslope tangent fitting a
Gaussian smoothing kernel was applied to the flow curves,
corresponding to sigma = 0.62 ms (for a heart rate of 60
beats per minute; i.e. sigma value 0.025). The amount of
smoothing was determined by visual inspection of the flow
curves, and can be changed manually as needed. The time
delay (Δt) between the intersection points was used as in-
put for calculation of the CMR-PWV. The CMR-PWV was
thus calculated by dividing the measured aortic centre-line
distance between the ascending aorta and diaphragm level
phase-encoded velocity flow planes by the Δt between the 2
flow curves.
Due to concomitant or Eddy current background phase
errors a baseline shift of the flow curves may be seen [14].
Built-in Eddy current compensation may solve this, but is
also vendor-dependent. Therefore the PWV module also
includes an option to adjust the individual flow curves to
correct for this, both automatically and manually. The
automatic method calculated the baseline as the mean
flow rate during 62.5–87.5 % of the cardiac cycle. As this
automatic correction may fail in cases with significant
aortic regurgitation, a manual method for baseline correc-
tion was also implemented. Neither the manual nor the
automatic method was however applied in the current
study, as baseline shift was not seen.
Three observers blinded to other patient information
and each other’s results performed independent CMR
analyses. The observers had different experience in CMR
(15 years, 4 years and less than 1 year). All observers
also repeated their measurements more than 10 days later.
The CMR-PWV data presented, except for comparisons
between observers, are based on measurements by the
most experienced observer.
Applanation tonometry
Carotid-femoral PWV was measured noninvasively by
AT according to recommended clinical standards [15].
Even though considered clinical standard today, as it is
widely available, it is important to note that AT is not a
gold standard. In the current study it is thus used as a
comparison between non-invasive tools. Carotid and
femoral pulse wave recordings were performed in supine
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subjects after 15 min of rest. Measurements were per-
formed on the right common carotid artery [C] and the
right femoral artery [F] using the widely available Sphyg-
moCor device (AtCor Medical, Australia). Intravessel
distance between measurement points was defined by
approximation from body surface tape measurements
and calculated as suprasternal notch to [F] - suprasternal
notch to [C] [16].
The AT-PWV was calculated using commercial software
(SphygmoCor Cardiovascular Management Suite; AtCor
Medical, Australia) based on pulse transit time and the
approximate intravessel distance between the two meas-
urement points.
Statistical analysis
Data were expressed as median (range) or mean ± SD.
Statistical analyses were performed using Prism 6
(GraphPad Software, La Jolla, CA, USA). The observer
variability was determined as bias ± SD and agreement
was calculated according to Bland-Altman with 95 %
limits of agreement. The Student’s two-tailed t-test was
applied for testing of statistically significant differences
in normally distributed data, whereas Fisher’s exact test
was performed on categorical data, with p < 0.05 consid-
ered statistically significant.
Results
Demographic and clinical characteristics are summarised
in Table 1.
Computer phantoms
The results of the computer phantoms are summarised
in Table 2 and Fig. 2. The PWV error seems to increase
with increasing number of time frames. The reason for
this is that inadequate time resolution (number of time
frames) generates smoothing, which prevents calculation
of correct slopes and thus leads to incorrect PWV. For
each true PWV there is a certain number of time frames
where the error is maximal, and thereafter the error
again decreases with increasing number of time frames.
From 35 time frames per cardiac cycle, a plateau in the
error of the PWV estimation is visible, corresponding to
a required time resolution of at least 30 ms to accurately
quantify PWV over a range of 2 – 20 m/s using phase-
contrast CMR. The temporal resolution of at least 30 ms
yielded a bias of 0.27 ± 0.32 m/s between calculated and
true PWV in the computer phantoms. All human CMR
flow data were thus acquired using a temporal resolution
of at least 30 ms; i.e. set above 35 time frames also con-
sidering the individual cardiac frequency.
Fig. 1 The graphical user interface for pulse wave velocity assessment. The oblique sagittal image of the aorta (left) shows the perpendicular flow
measurement planes (white lines) in the ascending aorta and at the level of the diaphragm. The centre-line aortic distance between flow planes
are shown as a yellow line with cross marks. The graph (right) shows the flow curves and respective upslope tangents with their baseline intersection
points giving the time delay between flow curves (Δt; dashed part of the baseline tangent)
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For the Gaussian smoothing sigma value, a 50 % reduction
in sigma from 0.68 ms to 0.34 ms resulted in a PWV change
of -0.02 ± 0.12 m/s, indicating low impact on standard flow
data. In images with a lower signal-to-noise ratio, however, a
change in sigma may render more adequate fitting data.
CMR
The CMR-PWV was feasible to perform in all subjects.
As good signal-to-noise ratio was seen in all cases in
the current study, sigma was not manually altered and
thus sigma = 0.025 was used for all CMR-PWV
analyses.
The CMR-PWV was statistically significantly higher
in patients compared with younger healthy subjects
(p < 0.0001; Table 3). Intraobserver variability for CMR-PWV
for the 3 observers was 0 ± 0.03 m/s (15 years), -0.04 ±
0.33 m/s (4 years), and -0.02 ± 0.30 m/s (<1 year), respect-
ively. The PWV interobserver variability between the 2 less
experienced observers and the more experienced observer
was for 4 vs. 15 years -0.01 ± 0.32 m/s and for <1 vs. 15 years
0.01 ± 0.30 m/s, and between the 2 less experienced ob-
servers PWV interobserver variability was 0.02 ± 0.38 m/s
(Fig. 3). The observer variability can be related to aortic
distance measurements between flow planes and flow
measurements. Intraobserver variability for the aortic
centre-line distance between flow planes was 0.2 ±
1.2 mm (15 years), -0.1 ± 4.8 mm (4 years), and -1.0 ±
5.9 mm (<1 year), respectively, with an average distance
between flow planes of 250 ± 30 mm. Interobserver
variability for aortic centre-line distance between flow
planes, comparing the 2 less experienced observers and the
more experienced observer, was for 4 vs. 15 years -1.2 ±
4.8 mm and for <1 vs. 15 years -1.9 ± 4.7 mm. Intraob-
server variability for flow measurements, calculated as
the time difference Δt between flow curves was 0 ±
0.1 ms (15 years), 0.3 ± 1.7 ms (4 years) and 0.3 ±
2.5 ms (<1 year), respectively. Corresponding inter-
observer variability was for 4 vs. 15 years -0.2 ± 1.4 ms
and for <1 vs. 15 years -0.3 ± 3.3 ms. Interobserver
variability did not differ between 1.5 T and 3 T (all p >
0.12).
Table 1 Demographic and clinical characteristics of the study population
Healthy young Patients p
Number of subjects 13 13
Male/Female 8/5 6/7 0.70
Age (years) 26 (18 – 43) 61 (52 – 72) <0.0001
BMI (kg/m2) 20 (17 – 24) 27 (22 – 35) <0.0001
Systolic blood pressure (mmHg) 120 (100 – 140) 130 (110 – 160) 0.02
Diastolic blood pressure (mmHg) 80 (55 – 80) 80 (60 – 90) 0.17
History of smokinga 0 6 0.01
History of CAD 0 4 0.10
Statins 0 13 <0.0001
Antihypertensive drugsb 0 12 <0.0001
Diabetesc 0 2 0.48
aNo current smoker. b8 patients with ACE inhibitors, of which 1 with added diuretics, 1 with added calcium channel blockers, and 1 with added beta adrenolytics.
Four patients with AT receptor blockers, of which 1 with added beta adrenolytics, 1 with added beta adrenolytics and diuretics, and 1 with added beta adrenolytics,
diuretics and alpha adrenolytics. cAll patients without insulin dependent diabetes
Table 2 The PWV median errors for different number of time
frames/temporal resolution based on 210 computer phantoms




20 50.0 2.36 21.3
21 47.6 1.51 17.2
22 45.5 0.72 10.4
23 43.5 0.16 9.1
24 41.7 -0.02 6.5
25 40.0 -0.39 4.4
26 38.5 -1.61 10.8
27 37.0 -2.74 18.1
28 35.7 -2.39 21.3
29 34.5 -1.83 16.2
30 33.3 -1.29 11.4
31 32.3 -0.76 6.7
32 31.3 -0.42 5.1
33 30.3 -0.20 2.6
34 29.4 -0.11 1.3
35 28.6 0.10 0.9
36 27.8 0.48 3.6
37 27.0 0.46 4.1
38 26.3 0.30 3.0
39 25.6 0.23 2.4
40 25.0 0.17 1.8
Errors are expressed as median errors for all velocities in the range of 2–20 m/s
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Applanation tonometry
The AT-PWV values were, as for CMR-PWV, statistically
significantly higher in patients than in younger healthy
subjects (p < 0.0001; Table 3).
The AT-PWV was statistically significantly higher than
CMR-PWV for healthy young subjects (5.6 ± 0.7 vs.
4.5 ± 0.8; p < 0.0001). For patients a similar trend was
found, however not statistically significant (9.0 ± 2.2 vs.
7.8 ± 2.2; p = 0.07) (Table 3; Fig. 4).
The bias and variability between AT-PWV and CMR-
PWV were similar at 1.5 T and 3 T (1.5 T: 1.1 ± 2.4 m/s;
3 T: 1.6 ± 1.3 m/s; p = 0.56).
Discussion
This study shows that an acquired temporal resolution of at
least 30 ms is necessary to obtain accurate and precise quan-
titative flow data for CMR-PWV over the range 2–20 m/s,
representative of PWV in the human aorta. Further, a new
freely available tool for research was developed and
used to measure CMR-PWV in healthy young subjects
and in patients, showing low intra- and interobserver
variability also for less experienced CMR observers.
The current study showed lower PWV in the younger
healthy cohort compared with older patients at risk for
CVD, as expected [1, 8]. The current study also showed
slightly higher PWV for the healthy young cohort com-
pared with data from an equivalent age group in a recent
study including PWV in only the aortic arch (4 m/s),
[10] but lower than a study also including parts of the
abdominal aorta (5.6 m/s) [17]. This difference may be
explained by that measurements for PWV are related to
the elastic properties of the vessels, which vary along the
arterial tree, with more elastic proximal segments and
stiffer distal segments. In an invasive human study, pulse
wave velocity increased from 5 m/s in the ascending
aorta to 6 m/s in the abdominal aorta, and up to 9 m/s in
the iliac and femoral arteries [18]. A recent CMR-PWV
study however showed a different order of PWV, with
highest PWV in the aortic arch (8–9 m/s), lower PWV in
the iliofemoral segment (7–8 m/s), and lowest PWV in
the thoracoabdominal segment (5–7 m/s) [11]. This dif-
ference is not explained and age groups are similar.
Other CMR-PWV studies however also show approxi-
mately 4–6 m/s in the aortic arch, [1, 10] or approximately
6 m/s in the thoracic segment, [17] both comparable with
the original invasive measurements by Latham et al. [18].
The CMR-PWV was determined with low intraobserver
variability in the current study using the TTF approach,
which has been previously shown to have high reprodu-
cibility [7, 9]. Further, also the less experienced CMR
observers in the current study showed low interobserver
variability versus the more experienced observer. A previ-
ous study showed similar interobserver variability between
experienced observers (-0.1 ± 0.3 m/s), [9] which together
with the current study indicates that CMR-PWV can be
precisely performed also with less CMR experience.
The AT-PWV overestimated CMR-PWV by 1.1 ± 0.7 m/s
in young healthy subjects and 1.6 ± 2.7 m/s in the older
patients. This is a similar trend compared with previ-
ously published data where the corresponding reported
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Fig. 2 Median percentage PWV errors for number of time-frame
samples for flow data from 210 computer phantoms. For clarity, 4
cases representative of different PWV are shown. All computer
phantoms were however used for cut-off calculations. A plateau in
the median PWV error is found from 35 time frames per cardiac
cycle, corresponding to a temporal resolution of at least 30 ms at a
heart rate of 60 beats per minute (top). The grey vertical line represents
the cut-off 35 time frames, and the grey horizontal lines indicate the
maximum PWV errors (±6 %) above the cut-off 35 time frames. The
median error for 35 time frames was 0.27 ± 0.32 m/s between calculated
and true PWV in phantoms, and is visualised in the identity plot
(bottom). The dashed line indicates line of identity







Healthy young 5.6 ± 0.7 4.5 ± 0.8 <0.0001
Patients 9.0 ± 2.2 7.8 ± 2.2 0.07
p (between groups) <0.0001 <0.0001
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differences were 0.43 m/s and 0.64 m/s [17]. Thus,
PWV values are not interchangeable between AT and
CMR. In AT-based measurements, age-related elong-
ation or increased tortuosity of the aorta in disease may
play a role, as this cannot be accounted for using stand-
ard surface tape estimates. Pure age-related elongation
of the ascending aorta is considered to be of minor
importance for AT-PWV, as this part of aorta is not
included in distance measurements for calculation of
AT-PWV [19]. When AT-PWV values are compared
with CMR-PWV however also the ascending aorta is
of importance but even more so the increased tortuos-
ity of the abdominal aorta, which has impact on the
vessel distance, not being accurate by surface tape esti-
mates. In CMR-PWV accurate aortic centre-line distance
measurements can be acquired in all cases, either by ad-
equate angulation of a stack of oblique sagittal images
covering the aorta, which can be combined into a 3D slab
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Fig. 3 Bland-Altman plots showing intra- (top) and interobserver (bottom) CMR-PWV variability. Intraobserver variability for CMR-PWV was low for
all 3 observers, 0 ± 0.03 m/s (15 years; left), -0.04 ± 0.33 m/s (4 years; middle), and -0.02 ± 0.30 m/s (<1 year; right), respectively. The interobserver
variability was also generally low, for 4 vs. 15 years -0.01 ± 0.32 m/s (left), <1 vs. 15 years 0.01 ± 0.30 m/s (middle), and <1 vs. 4 years 0.02 ± 0.38 m/s
(right). Dotted lines indicate mean differences and dashed lines represent 95 % limits of agreement














































Fig. 4 Bland-Altman plots showing AT-PWV vs. CMR-PWV. The AT-PWV overestimated CMR-PWV by 1.1 ± 0.7 m/s in younger healthy subjects (left)
and by 1.6 ± 2.7 m/s in patients (right). Dotted lines indicate mean differences and dashed lines represent 95 % limits of agreement. Also note
the PWV differences between younger healthy subjects and older patients where PWV is lower and less dispersed in healthy young subjects
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for proper distance measurements in software such as the
one used in the current study, or directly assessed using
3D angiography techniques applying curved multiplanar
reconstruction, with or without contrast agent.
The lack of availability of CMR-PWV software is cur-
rently viewed as a major limitation to the wider use of
CMR-PWV [12]. The current study developed a new tool
for measuring CMR-PWV, showing values corresponding
to previous studies in comparable cohorts, and also a cor-
responding relation to AT-PWV. The 2D through-plane
phase-contrast MRI method was chosen, as it is widely
used in clinical CMR routine. This, together with the
straightforward TTF method used in post-processing
makes this approach attractive for clinical use. Other
CMR-based PWV techniques are available, but are both
more advanced and less elementary for clinical applica-
tion [20, 21]. Further, the method applied in the current
study has been shown to be the most reproducible in a
recent comparison between transit time, cross-correlation
and flow-area methods for CMR-PWV assessment [9].
Limitations
The time of day, association with meals, sleep, caffeine
and smoking may all impact PWV [15]. All these were
corrected for in the current study except for the exact
time of day the examination was performed. The differ-
ences related to time of day are however small and all
subjects underwent AT within 2 h after CMR so potential
changes are not considered to have impact on results. The
distribution between 1.5 T and 3 T was not randomised
but rather resulted from centre logistics. It is however
unlikely that randomisation would significantly alter the
results. The current study did not use invasive haemo-
dynamics as a gold standard but rather compared two
non-invasive methods, which may be considered a limita-
tion. Invasive measures were however not necessary to
show the readiness of PWV-CMR imaging and low vari-
ability using the proposed tool.
Conclusions
Computer phantoms showed that an acquired temporal
resolution of at least 30 ms (corresponding to 35 acquired
time frames at a heart rate of 60 beats per minute) is ne-
cessary to obtain accurate and precise quantitative flow
data for CMR-PWV over the range 2–20 m/s in the thor-
acic aorta. A new tool, freely available for research, was
used to measure PWV in healthy young subjects and in
patients showing low intra- and interobserver variability
also for less experienced CMR observers.
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